Delivery Order SPE2DB24D8001-SPE2DB25FKZHD

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, identified as SPE2DB24D8001, is part of the DLA Troop Support Medical's ECAT Generation V Program and has a ceiling value of $11,580.84. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. It is a firm fixed-price,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, identified as SPE2DB24D8001, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7C5F, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,837.38 and a period of performance through January 26, 2024. The contract does not have a set-aside designation, indicating that it was competed...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZV, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The contract has a ceiling value of $11,519.50 and is structured as a firm fixed-price delivery order. It is not designated as a set-aside contract. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit Subchapter S corporation. The company specializes in providing...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $6,650.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) named SPE2DB24D8001, which is part of the DLA Troop Support Medical's ECAT Generation V Program. The contract provides for the delivery of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract falls under the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Through this single-award IDC, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYZJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Dakota Drug, Inc. The contract is a delivery order valued at $6,456.93, with a firm fixed-price pricing structure. Dakota Drug, Inc. is a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of pharmaceutical products, medical supplies, and healthcare equipment. The contract award has a ceiling value of $3,566.24 and an ultimate completion date of April 19, 2024. The contract does not have a set-aside designation. Dakota Drug, Inc. specializes in supplying a diverse array of...
This federal contract award, identified as SPE2DX15D8001|SPE2DX23FBQCN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $7,745.85 firm fixed-price delivery order is for the provision of various pharmaceutical products and medical supplies, including insulin pens, inhalers, anticoagulants, and biologic drugs, to support U.S. Armed Forces medical...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKZHD
    Delivery Order

This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZHD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations.

The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, with a ceiling value of $2,148.25 and a performance period extending through March 3, 2025. Dakota Drug, Inc. holds a significant single-award IDC with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of medical products to various defense healthcare facilities. The contract award did not utilize any set-aside designation.

Generated 5/30/25, 10:10 AM